The post RFK Jr. Will Reportedly Link Autism To Tylenol Use During Pregnancy appeared on BitcoinEthereumNews.com. Topline A promised report from Health and Human Services Secretary Robert F. Kennedy Jr. will claim the use of the common painkiller Tylenol during pregnancy is a potential cause for autism, The Wall Street Journal reported, while the drug’s maker maintains the drug’s safety. The report is slated to publish this month. (Photo by Andrew Harnik/Getty Images) Getty Images Key Facts Kenvue, which owns McNeil Consumer Healthcare, the maker of Tylenol, told The Journal, “We have continuously evaluated the science and continue to believe there is no causal link between acetaminophen use during pregnancy and autism.” Acetaminophen, the key drug in Tylenol, is available in a variety of other over-the-counter pain-killers. The HHS report will include findings linking pregnant women’s use of the painkiller to autism and also will suggest folinic acid as a means of decreasing autism symptoms, according to the Journal. Forbes has reached out to HHS and Kenvue for comment. This is a developing story. Check back for updates. Source: https://www.forbes.com/sites/antoniopequenoiv/2025/09/05/rfk-jr-report-will-link-autism-to-tylenol-use-during-pregnancy-report-says/The post RFK Jr. Will Reportedly Link Autism To Tylenol Use During Pregnancy appeared on BitcoinEthereumNews.com. Topline A promised report from Health and Human Services Secretary Robert F. Kennedy Jr. will claim the use of the common painkiller Tylenol during pregnancy is a potential cause for autism, The Wall Street Journal reported, while the drug’s maker maintains the drug’s safety. The report is slated to publish this month. (Photo by Andrew Harnik/Getty Images) Getty Images Key Facts Kenvue, which owns McNeil Consumer Healthcare, the maker of Tylenol, told The Journal, “We have continuously evaluated the science and continue to believe there is no causal link between acetaminophen use during pregnancy and autism.” Acetaminophen, the key drug in Tylenol, is available in a variety of other over-the-counter pain-killers. The HHS report will include findings linking pregnant women’s use of the painkiller to autism and also will suggest folinic acid as a means of decreasing autism symptoms, according to the Journal. Forbes has reached out to HHS and Kenvue for comment. This is a developing story. Check back for updates. Source: https://www.forbes.com/sites/antoniopequenoiv/2025/09/05/rfk-jr-report-will-link-autism-to-tylenol-use-during-pregnancy-report-says/

RFK Jr. Will Reportedly Link Autism To Tylenol Use During Pregnancy

Topline

A promised report from Health and Human Services Secretary Robert F. Kennedy Jr. will claim the use of the common painkiller Tylenol during pregnancy is a potential cause for autism, The Wall Street Journal reported, while the drug’s maker maintains the drug’s safety.

The report is slated to publish this month. (Photo by Andrew Harnik/Getty Images)

Getty Images

Key Facts

Kenvue, which owns McNeil Consumer Healthcare, the maker of Tylenol, told The Journal, “We have continuously evaluated the science and continue to believe there is no causal link between acetaminophen use during pregnancy and autism.”

Acetaminophen, the key drug in Tylenol, is available in a variety of other over-the-counter pain-killers.

The HHS report will include findings linking pregnant women’s use of the painkiller to autism and also will suggest folinic acid as a means of decreasing autism symptoms, according to the Journal.

Forbes has reached out to HHS and Kenvue for comment.

This is a developing story. Check back for updates.

Source: https://www.forbes.com/sites/antoniopequenoiv/2025/09/05/rfk-jr-report-will-link-autism-to-tylenol-use-during-pregnancy-report-says/

Market Opportunity
SynFutures Logo
SynFutures Price(F)
$0.005897
$0.005897$0.005897
-1.09%
USD
SynFutures (F) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.